Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Chengjuan Chen, Dianxiang Lu, Tao Sun & Tiantai Zhang. (2022) JAK3 inhibitors for the treatment of inflammatory and autoimmune diseases: a patent review (2016–present). Expert Opinion on Therapeutic Patents 32:3, pages 225-242.
Read now
Read now
Xingrui He, Xiabin Chen, Hancheng Zhang, Tian Xie & Xiang-Yang Ye. (2019) Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015–2018). Expert Opinion on Therapeutic Patents 29:2, pages 137-149.
Read now
Read now
Jason G. Kettle, Annika Åstrand, Matthew Catley, Neil P. Grimster, Magnus Nilsson, Qibin Su & Richard Woessner. (2017) Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1. Expert Opinion on Therapeutic Patents 27:2, pages 127-143.
Read now
Read now
Articles from other publishers (10)
Lili Wang, Zhengyan Li, Tulin Lu, Lianlin Su, Chunqin Mao, Yiting Zhang, Xinrui Zhang, Xiaofeng Jiang, Hui Xie & Xiaoling Yu. (2023)
The potential mechanism of Choulingdan mixture in improving acute lung injury based on HPLC–Q‐TOF–MS, network pharmacology and
in vivo
experiments
. Biomedical Chromatography.
Crossref
Crossref
Márcia S. Martins, Isabel F. Almeida, Maria T. Cruz & Emília Sousa. (2023) Chronic pruritus: From pathophysiology to drug design. Biochemical Pharmacology 212, pages 115568.
Crossref
Crossref
Johan Mattsson, Elisabeth Israelsson, Karin Björhall, Linda Fahlén Yrlid, Kristoffer Thörn, Anna Thorén, Emelie Andersén Toledo, Lisa Jinton, Lisa Öberg, Cecilia Wingren, Sofia Tapani, Sonya G. Jackson, Gabriel Skogberg, Anders J. Lundqvist, Ramon Hendrickx, Anders Cavallin, Torben Österlund, Neil P. Grimster, Magnus Nilsson & Annika Åstrand. (2023) Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata. Skin Health and Disease 3:3.
Crossref
Crossref
Kuojun Zhang, Ke Ye, He Tang, Zhihao Qi, Tianyu Wang, Jie Mao, Xiangyu Zhang & Sheng Jiang. (2023) Development and Therapeutic Implications of Tyrosine Kinase 2 Inhibitors. Journal of Medicinal Chemistry 66:7, pages 4378-4416.
Crossref
Crossref
Sandra Ferreira, Emma Guttman-Yassky & Tiago Torres. (2020) Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib. American Journal of Clinical Dermatology 21:6, pages 783-798.
Crossref
Crossref
Qibin Su, Erica Banks, Geraldine Bebernitz, Kirsten Bell, Cassandra F. Borenstein, Huawei Chen, Claudio E. Chuaqui, Nanhua Deng, Andrew D. Ferguson, Sameer Kawatkar, Neil P. Grimster, Linette Ruston, Paul D. Lyne, Jon A. ReadXianyou Peng, Xiaohui Pei, Stephen Fawell, Zhanlei Tang, Scott Throner, Melissa M. Vasbinder, Haoyu Wang, Jon Winter-HoltRichard Woessner, Allan Wu, Wenzhan Yang, Michael Zinda & Jason G. Kettle. (2020)
Discovery of (2
R
)-
N
-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1
H
-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor
. Journal of Medicinal Chemistry 63:9, pages 4517-4527.
Crossref
Crossref
Hart S. Dengler, Xiumin WuIvan PengCornelia H. Rinderknecht, Youngsu KwonEric Suto, Pawan Bir KohliMarya LiimattaKathy BarrettJulia Lloyd, Gary CainMike Briggs, Stephanie AddoGary SalmonSavita Ubhayakar, Gauri Deshmukh, Sheerin K. Shahidi-Latham, Cristine M. Quiason-Huynh, Janet JackmanJohn LiuNicholas C. Ray, Simon C. Goodacre, Adam Johnson, Brent S. McKenzieWyne P. LeeMark ZakJane R. KennyNico Ghilardi. (2018) Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma. Science Translational Medicine 10:468.
Crossref
Crossref
Marian C. Bryan & Naomi S. Rajapaksa. (2018) Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances. Journal of Medicinal Chemistry 61:20, pages 9030-9058.
Crossref
Crossref
Neil P. Grimster, Erica Anderson, Marat Alimzhanov, Geraldine Bebernitz, Kirsten Bell, Claudio Chuaqui, Tracy Deegan, Andrew D. Ferguson, Thomas Gero, Andreas Harsch, Dennis Huszar, Aarti Kawatkar, Jason G. Kettle, Paul Lyne, Jon A. Read, Caroline Rivard Costa, Linette Ruston, Patricia Schroeder, Jie Shi, Qibin Su, Scott Throner, Dorin Toader, Melissa Vasbinder, Richard Woessner, Haixia Wang, Allan Wu, Minwei Ye, Weijia Zheng & Michael Zinda. (2018) Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors. Journal of Medicinal Chemistry 61:12, pages 5235-5244.
Crossref
Crossref
Daniella M. Schwartz, Yuka Kanno, Alejandro Villarino, Michael Ward, Massimo Gadina & John J. O'Shea. (2017) JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nature Reviews Drug Discovery 16:12, pages 843-862.
Crossref
Crossref